James C. Fanggiday

Most-cited papers

1. Erlotinib and pantoprazole: a relevant interaction or not?

   R. ter Heine, James C. Fanggiday, N. Lankheet, J. Beijnen +3 more

   2010British Journal of Clinical Pharmacology30 citations Open access

   Semantic Scholar

   Save

2. Effects of epicardial versus transvenous left ventricular lead placement on left ventricular function and cardiac perfusion in cardiac resynchronization therapy: A randomized clinical trial

   V. V. van Dijk, James C. Fanggiday, J. Balt, M. Wijffels +3 more

   2017Cardiovascular Electrophysiology15 citations

   Semantic Scholar

   Save

3. 109-05: Effects of epicardial versus transvenous left ventricular lead placement on cardiac perfusion, contractile force, and clinical performance in cardiac resynchronisation therapy; a randomized clinical trial

   V. V. van Dijk, James C. Fanggiday, M. Wijffels, J. Balt +3 more

   20160 citations Open access

   Semantic Scholar

   Save

4. Evaluation of bronchoscopy and 18F-FDG PET-CT in a fast track assessment of suspected lung cancer

   James C. Fanggiday, W. Dalinghaus, J. V. D. van den Brand, V. R. van der Pas +2 more

   20120 citations

   Semantic Scholar

   Save

5. Safety and Efficacy of Drug-Eluting Balloons in Percutaneous Treatment of Bifurcation Lesions : The DEBIUT ( D rugE luting B alloon in BI furcaton UT recht ) Registry

   James C. Fanggiday, P. Stella, S. H. Guyomi, P. Doevendans

   20080 citations

   Semantic Scholar

   Save